261 related articles for article (PubMed ID: 21818323)
1. 17β-Estradiol enhances breast cancer cell motility and invasion via extra-nuclear activation of actin-binding protein ezrin.
Zheng S; Huang J; Zhou K; Zhang C; Xiang Q; Tan Z; Wang T; Fu X
PLoS One; 2011; 6(7):e22439. PubMed ID: 21818323
[TBL] [Abstract][Full Text] [Related]
2. Extra-nuclear signalling of estrogen receptor to breast cancer cytoskeletal remodelling, migration and invasion.
Giretti MS; Fu XD; De Rosa G; Sarotto I; Baldacci C; Garibaldi S; Mannella P; Biglia N; Sismondi P; Genazzani AR; Simoncini T
PLoS One; 2008 May; 3(5):e2238. PubMed ID: 18493596
[TBL] [Abstract][Full Text] [Related]
3. Extra-nuclear signaling of progesterone receptor to breast cancer cell movement and invasion through the actin cytoskeleton.
Fu XD; Giretti MS; Baldacci C; Garibaldi S; Flamini M; Sanchez AM; Gadducci A; Genazzani AR; Simoncini T
PLoS One; 2008 Jul; 3(7):e2790. PubMed ID: 18665217
[TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor-alpha promotes breast cancer cell motility and invasion via focal adhesion kinase and N-WASP.
Sanchez AM; Flamini MI; Baldacci C; Goglia L; Genazzani AR; Simoncini T
Mol Endocrinol; 2010 Nov; 24(11):2114-25. PubMed ID: 20880986
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA/ROCK-2/moesin cascade.
He M; Cheng Y; Li W; Liu Q; Liu J; Huang J; Fu X
BMC Cancer; 2010 Apr; 10():170. PubMed ID: 20429915
[TBL] [Abstract][Full Text] [Related]
6. Progesterone receptor enhances breast cancer cell motility and invasion via extranuclear activation of focal adhesion kinase.
Fu XD; Goglia L; Sanchez AM; Flamini M; Giretti MS; Tosi V; Genazzani AR; Simoncini T
Endocr Relat Cancer; 2010 Jun; 17(2):431-43. PubMed ID: 20233709
[TBL] [Abstract][Full Text] [Related]
7. Estrogen stimulated migration and invasion of estrogen receptor-negative breast cancer cells involves an ezrin-dependent crosstalk between G protein-coupled receptor 30 and estrogen receptor beta signaling.
Zhou K; Sun P; Zhang Y; You X; Li P; Wang T
Steroids; 2016 Jul; 111():113-120. PubMed ID: 26850467
[TBL] [Abstract][Full Text] [Related]
8. Paxillin, a novel controller in the signaling of estrogen to FAK/N-WASP/Arp2/3 complex in breast cancer cells.
Shortrede JE; Uzair ID; Neira FJ; Flamini MI; Sanchez AM
Mol Cell Endocrinol; 2016 Jul; 430():56-67. PubMed ID: 27095481
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor alpha interacts with Galpha13 to drive actin remodeling and endothelial cell migration via the RhoA/Rho kinase/moesin pathway.
Simoncini T; Scorticati C; Mannella P; Fadiel A; Giretti MS; Fu XD; Baldacci C; Garibaldi S; Caruso A; Fornari L; Naftolin F; Genazzani AR
Mol Endocrinol; 2006 Aug; 20(8):1756-71. PubMed ID: 16601072
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
[TBL] [Abstract][Full Text] [Related]
11. Comparative actions of progesterone, medroxyprogesterone acetate, drospirenone and nestorone on breast cancer cell migration and invasion.
Fu XD; Giretti MS; Goglia L; Flamini MI; Sanchez AM; Baldacci C; Garibaldi S; Sitruk-Ware R; Genazzani AR; Simoncini T
BMC Cancer; 2008 Jun; 8():166. PubMed ID: 18541028
[TBL] [Abstract][Full Text] [Related]
12. Roles of p-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation.
Lee JH; Katakai T; Hara T; Gonda H; Sugai M; Shimizu A
J Cell Biol; 2004 Oct; 167(2):327-37. PubMed ID: 15504914
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of MNAR promotes estrogen activation of phosphatidylinositol 3-kinase.
Greger JG; Fursov N; Cooch N; McLarney S; Freedman LP; Edwards DP; Cheskis BJ
Mol Cell Biol; 2007 Mar; 27(5):1904-13. PubMed ID: 17194752
[TBL] [Abstract][Full Text] [Related]
14. Src kinase mediates phosphatidylinositol 3-kinase/Akt-dependent rapid endothelial nitric-oxide synthase activation by estrogen.
Haynes MP; Li L; Sinha D; Russell KS; Hisamoto K; Baron R; Collinge M; Sessa WC; Bender JR
J Biol Chem; 2003 Jan; 278(4):2118-23. PubMed ID: 12431978
[TBL] [Abstract][Full Text] [Related]
15. Osmotic cell shrinkage activates ezrin/radixin/moesin (ERM) proteins: activation mechanisms and physiological implications.
Rasmussen M; Alexander RT; Darborg BV; Møbjerg N; Hoffmann EK; Kapus A; Pedersen SF
Am J Physiol Cell Physiol; 2008 Jan; 294(1):C197-212. PubMed ID: 17977945
[TBL] [Abstract][Full Text] [Related]
16. Estrogen promotes progression of hormone-dependent breast cancer through CCL2-CCR2 axis by upregulation of Twist via PI3K/AKT/NF-κB signaling.
Han R; Gu S; Zhang Y; Luo A; Jing X; Zhao L; Zhao X; Zhang L
Sci Rep; 2018 Jun; 8(1):9575. PubMed ID: 29934505
[TBL] [Abstract][Full Text] [Related]
17. Membrane ERα attenuates myocardial fibrosis via RhoA/ROCK-mediated actin remodeling in ovariectomized female infarcted rats.
Lee TM; Lin SZ; Chang NC
J Mol Med (Berl); 2014 Jan; 92(1):43-51. PubMed ID: 24292258
[TBL] [Abstract][Full Text] [Related]
18. Activated protein C enhances cell motility of endothelial cells and MDA-MB-231 breast cancer cells by intracellular signal transduction.
Gramling MW; Beaulieu LM; Church FC
Exp Cell Res; 2010 Feb; 316(3):314-28. PubMed ID: 19891966
[TBL] [Abstract][Full Text] [Related]
19. N,N'-dinitrosopiperazine-mediated ezrin protein phosphorylation via activation of Rho kinase and protein kinase C is involved in metastasis of nasopharyngeal carcinoma 6-10B cells.
Tang F; Zou F; Peng Z; Huang D; Wu Y; Chen Y; Duan C; Cao Y; Mei W; Tang X; Dong Z
J Biol Chem; 2011 Oct; 286(42):36956-67. PubMed ID: 21878630
[TBL] [Abstract][Full Text] [Related]
20. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.
Boerner JL; Gibson MA; Fox EM; Posner ED; Parsons SJ; Silva CM; Shupnik MA
Mol Endocrinol; 2005 Nov; 19(11):2660-70. PubMed ID: 15976008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
